Search Orphan Drug Designations and Approvals
-
Generic Name: | Human immunoglobin anti-CD30 monoclonal antibody |
---|---|
Date Designated: | 01/10/2006 |
Orphan Designation: | Treatment of CD30+ T-cell lymphoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Bristol-Myers Squibb 519 Route 173 West Bloombury, New Jersey 08804 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-